Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 11 May 2022 for Integrated Biopharma INC, €22k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
e. Gerald Kay: trading record in brief
All filings by e. Gerald Kay on record concern Integrated Biopharma Inc, in the capacity of chief executive. Activity is concentrated on a single trading day, 6 May 2022, with 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 11 May 2022: an option exercise of €22k, in Integrated Biopharma Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to e. Gerald Kay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
100,000 shares@ US$0.230.51% mcap50.0% of flowCommon StockSEC:0001053310-22-000002:0
100,000 shares@ US$0.23100.0% of flowCommon StockSEC:0001053310-22-000001:0
2 of 2 declarations
